immunoscintigraphy

PROCEDURE6 trials

Sponsors

Gilead Sciences, Memorial Sloan Kettering Cancer Center, Roswell Park Cancer Institute, Barbara Ann Karmanos Cancer Institute, Center of Molecular Immunology (CIM)

Conditions

AnemiaBreast CancerColorectal CancerLymphomaMetastatic CancerMyelodysplastic SyndromesPrecancerous ConditionProstate Cancer

Phase 2

Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma

Gilead SciencesLymphoma

Start: 1997-03-31Target: 60Updated: 2021-08-16

Nimotuzumab cold kit for the immunodiagnosis of solid tumors

Active, not recruitingRPCEC00000290

Center of Molecular Immunology (CIM)Tumors of head and neck, lung and gliomas

Start: 2019-09-30Updated: 2026-03-30

Phase 3

Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma

Gilead SciencesLymphoma

Start: 1997-03-31Target: 100Updated: 2021-08-16

Unknown Phase

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

Memorial Sloan Kettering Cancer CenterBreast Cancer

Start: 2006-07-31Target: 75Updated: 2014-01-06

DNA Changes That Affect Vitamin D Metabolism in Patients With Colorectal Cancer Receiving Vitamin D Supplements

CompletedNCT00550563

Roswell Park Cancer InstituteColorectal Cancer

Start: 2007-08-31End: 2010-07-31Updated: 2017-04-04

Proteases in Patients With Prostate Cancer That Has Spread to the Bone

CompletedNCT00899665

Barbara Ann Karmanos Cancer InstituteAnemia, Metastatic Cancer, Myelodysplastic Syndromes +2

Start: 2001-07-31End: 2008-01-31Updated: 2014-02-11